WASHINGTON, Sept. 15 -- Engineered Tissue Solutions, Rolla, Missouri, has submitted a public comment letter to the Centers for Medicare & Medicaid Services (CMS) concerning the proposed changes to the reimbursement structure for skin substitute products under the Physician Fee Schedule and the Outpatient Prospective Payment System for calendar year 2026. The organization commended CMS for its ongoing efforts to enhance transparency and promote equitable reimbursement while addressing rising heal more ST